The changing competitive landscape
The Central Nervous System (CNS) pharmaceutical markets have been led by a number of blockbuster products in recent history, and the short- to mid-term future will see a number of key patent expiries. This situation, together with continued unmet medical needs and an increasing consumer and regulatory focus on side effects, necessitates a new generation of innovation and strategic marketing to maintain 'branded' control of the market and blockbuster potentials. The requirement for innovation is opening a market, normally dominated by the major pharma players, to smaller biotech companies, creating a market where partnership opportunities abound.
Key issues
Our research answers your key questions regarding the following issues:
• What's in the pipeline for specific therapy areas?
• How successful will pipeline launches be?
• What gaps exist in CNS pipeline development?
• What are the relative market sizes within CNS?
• Which secondary indications will provide potential for marketed products?
• How do physicians segment their patients?
• Which segments offer commercial potential?
• Who are the key players in influencing prescribing choice?
• How are key players effectively targeted?
Datamonitor’s expertise
Datamonitor's CNS Strategic Planning Program (SPP) offers research, analysis and advisory services that provide an understanding of the competitive landscape to support informed strategic decision-making in your company.
Targeting Innovation – Significant unmet medical need remains in many CNS disorders. Our analysts draw on primary research with physicians, opinion leaders and patient groups, in addition to attendance at scientific congresses and secondary research, to define potential revenue-producing avenues of innovation. Currently marketed and pipeline therapies are reviewed against these criteria to produce a gap analysis, providing an assessment of available target opportunities.
Brand Positioning – As prescribers see increasing homogeneity between products, defining and owning your target segment becomes more difficult. Datamonitor's primary research into physician perception and brand positioning is the basis for our expert analysis and recommendations on key marketing messages that are fundamental to maximizing return.
Regulatory Restriction – The success of licensing, launch strategies, marketing and lifecycle management is dependent on the regional regulatory environment. Datamonitor’s analysis provides advice on country-by-country regulatory issues and assesses the
impact of previous strategies via case studies.
Market Maturity – As a market matures, brands need to be implementing marketing strategies to ensure brand loyalty, providing differentiation and buoyancy in the face of generic competition. With SSRIs, novel anticonvulsants and atypical antipsychotics seeing generic entrants over the next few years, novel drugs and current therapies must look to new strategies and licenses to ensure success. Datamonitor CNS analysts evaluate a number of such approaches in our commercial insights reports.
• What are the unmet clinical needs in the market?
• Which marketing messages are key to success?
• What role does patient compliance play in commercial success in psychiatry?
• How can patient compliance be improved?
Treatment of additional comorbid conditions
5%
Causing sedation
5%
Onset of action
8%
Patient compliance
8%
Ef f ective in previous treatment f ailures
10%
Cost of drug
5%
Causing side ef f ects
12%
Treatment of acute symptoms
21%
Improvement in quality of lif e
13%
Use in maintenance therapy
13%
Importance of broader drug attributes on therapy choice for neuropathic pain,
2003
Primary research with physicians treating neuropathic pain clearly identifies differential weighting on a number of drug attributes.
Note: Physicians were asked to distribute 100 points across the 10 broader drug attributes.
Source: Datamonitor NPIS 2003: Q8.3 (DMHC1861)
www .dat amonitor .com
Your SPP components
1 – Pipeline Analysis
R&D pipeline analysis by indication/drug class, for products from early to late stage development. Key developmental agents are profiled and their commercial potential assessed based on the extent to which they meet unmet needs and compare to other products.
2 – Stakeholder Insight
Analysis of key influences on patient management and prescribing behavior by indication. Focus is on physician perceptions of patient segmentation, product positioning and unmet needs.
What is an SPP?
An SPP is a continous advisory service, designed as a full support package to inspire and empower you in your business decision-making.
It comprises a combination of Datamonitor products and services, that draws on our unique information resources:
•
3 – Commercial Analysis •
Inline product, portfolio management and market analysis by indication/drug class. •
The focus is on the current and future dynamics of currently marketed drugs drawing
panels
datasets
analysis
on key case studies including forecasts to 2012.
4 – Market briefs
Shorter reports designed to be responsive to market developments and client needs.
5 – Analyst support
Additional expertise available to provide more tailored in-depth understanding of topics covered in the syndicated portfolio.
Recent titles
But an SPP is more than just data and analysis. It gives you the opportunity to access our full range of expertise, including our analysts who are on hand to give you ad hoc support and discuss any of our research findings. In this way, you’ll find an SPP gives you a vital dimension of market intelligence –
knowledge, interpretation and a fresh
• Stakeholder Insight: ADHD – Prescriber Attention Still Held by Short Acting Stimulant Drugs Published: Sep-04
• Commercial Insight: Anticonvulsants – How to Avoid a Brand Identity Crisis by Choosing Your Battlegrounds Carefully
Published: Sep-04
• Commercial Insight: Parkinson's Disease – Increased Focus on Earlier Treatment and Managing Levodopa Complications Will Drive Market Growth
Published: Aug-04
• Insomnia – Wake-Up Call for a Sleepy
Market
Published: Jul-04
• Pipeline Insight: Alzheimer's Disease – A Busy Future, with Diagnosis, Disease Modification and Prevention Key
to Growing Market
Published: Jul-04
perspective.
About Datamonitor
Market information is the lifeblood of any company: not just information, but the insight and intuition that go with it. Every year, Datamonitor helps people
in 5,000 of the world’s leading businesses with exactly this.
Coverage of Datamonitor’s central
Product development and commercialization
Pipeline analysis portfolio
Targeting and influencing the market
Market and competitive intelligence
Corporate strategy and
business planning
Whether it’s information for new products, M&A, restructuring, investing or overall market awareness, we provide the kind
nervous system research
Stakeholder analysis portfolio
Commercial analysis portfolio
Analyst support
Global consultancy expertise
Expert panels
of service quality and sophistication of data that few can match.
To find out how we can help you, contact us using the details below.
Datamonitor Europe
Charles House
108-110 Finchley Road London NW3 5JJ United Kingdom
t: +44 20 7675 7000
f: +44 20 7675 7500
e: ukinfo@datamonitor.com
Datamonitor USA
245 Fifth Ave
4th Floor
New York NY10016
USA
t: +1 212 686 7400
f: +1 212 686 2626
e: usinfo@datamonitor.com
Datamonitor Germany
Kastor & Pollux
Platz der Einheit 1
60327 Frankfurt
Deutschland
t: +49 69 9750 3119
f: +49 69 9750 3320
e: deinfo@datamonitor.com
Datamonitor Asia Pacific
Darling Park
Tower 2, Level 21
201 Sussex Street
Sydney NSW 2000
Australia
t: +61 2 9006 1526
f: +61 2 9006 1559
e: apinfo@datamonitor.com
Datamonitor Japan
Wakamatsu Bldg 7F
3-3-6 Nihonbashi-Honcho
Chuo-ku
Tokyo, 103-0023
Japan
t: +81 3 6202 7681
f: +81 3 4512 8117
e: jpinfo@datamonitor.com
www .dat amonitor .com
Place your order now...
Fax back to +44 20 7675 7016 (from Europe) or 212 686 2626 (from the US)
I would like to order:
Product title Product code Price £ / € / $ / ¥ *
__________________________________________________________________ ___________________ __________________
__________________________________________________________________ ___________________ __________________
__________________________________________________________________ ___________________ __________________
__________________________________________________________________ ___________________ __________________
__________________________________________________________________ ___________________ __________________
__________________________________________________________________ ___________________ __________________
__________________________________________________________________ ___________________ __________________
__________________________________________________________________ ___________________ __________________
* Please refer to our website www.datamonitor.com for up-to-date prices
Complete your details:
Name
Job Title
Department
Company
Address
State/Province
Post Code/ZIP
Country
Email
Tel
Complete payment details:
Please indicate your preferred currency option: UK£ Euro€ US$ Yen¥
I enclose a check payable to Datamonitor plc for _________ (+ p+p $30 UK / $60 rest of world) Please invoice my company for _______________________ (+ p+p $30 UK / $60 rest of world) Please debit my credit/charge card
Amex Visa Diners Mastercard
Card No ______________________________________________________________________ Expiry Date _________ / _________ Cardholder Signature ___________________________ Cardholder address____________________________________________________________ Please supply purchase order number here if required by your accounts department:
_____________________________________________________________________________
EU companies (except UK) must supply: VAT / BTW / MOMS / MWST / IVA / FPA number:
___________________________________________________________________________________________
Fax Datamonitor products and services are supplied under Datamonitor’s standard terms and conditions, copies of which are available on request. Payment must be received within 28 days of receipt of invoice.
Sign below to confirm your order:
______________________________________________________________________
I do not want to receive future mailings from Datamonitor and its related companies. Occasionally, our client list is made available to other companies for carefully selected mailings. Please check here if you do not wish to receive such mailings.
From Europe: tel: +44 20 7675 7000 fax: +44 20 7675 7016 email: ukinfo@datamonitor.com From Germany: tel: +49 69 9750 3119 fax: +49 69 9750 3320 email: deinfo@datamonitor.com From the US: tel: +1 212 686 7400 fax: +1 212 686 2626 email: usinfo@datamonitor.com From Asia Pacific: tel: +61 2 9006 1526 fax: +61 2 9006 1559 email: apinfo@datamonitor.com
Contact us to find out more about our products and services
|
